Kimata Jason T相关文献与解析，生知库 | 链接生命科学的每一步

Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV

局部炎症小体抑制可减轻HIV皮下长效抗逆转录病毒疗法引起的异物反应。

doi:10.1016/j.jconrel.2025.114559

Facchi, Ilaria; Di Trani, Nicola; Caffey, Camden; Nguyen, Thi Thao Linh; Liu, Yongbin; Zheng, Junjun; Mai, Junhua; Pons-Faudoa, Fernanda P; Xu, Yitian; Chen, Shu-Hsia; Kimata, Jason T; Nichols, Joan E; Chua, Corrine Ying Xuan; Grattoni, Alessandro

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H

HIV-1 F 亚型整合酶催化核心结构域外部的多态性会导致整合酶抑制剂耐药突变 Q148H 背景下复制能力的严重丧失。

期刊:Journal of Antimicrobial Chemotherapy

影响因子:3.6

doi:10.1093/jac/dkac238

Aulicino, Paula C; Momin, Zoha; Rozenszajn, Mijael; Monzon, Arturo; Arazi-Caillaud, Solange; Bologna, Rosa; Mangano, Andrea; Kimata, Jason T

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies

通过促进细胞凋亡和抑制自噬清除HIV-1或SIV病毒库：以治愈为导向的策略中靶向细胞内分子

期刊:Journal of Leukocyte Biology

影响因子:3.1

doi:10.1002/JLB.4MR0222-606

Chen, Min; Li, Min; Budai, Marietta M; Rice, Andrew P; Kimata, Jason T; Mohan, Mahesh; Wang, Jin

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

酵母表达的重组SARS-CoV-2受体结合域RBD203-N1作为COVID-19候选蛋白疫苗

期刊:Protein Expression and Purification

影响因子:1.2

doi:10.1016/j.pep.2021.106003

Chen, Wen-Hsiang; Pollet, Jeroen; Strych, Ulrich; Lee, Jungsoon; Liu, Zhuyun; Kundu, Rakhi Tyagi; Versteeg, Leroy; Villar, Maria Jose; Adhikari, Rakesh; Wei, Junfei; Poveda, Cristina; Keegan, Brian; Bailey, Aaron Oakley; Chen, Yi-Lin; Gillespie, Portia M; Kimata, Jason T; Zhan, Bin; Hotez, Peter J; Bottazzi, Maria Elena

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

受体结合域重组蛋白在明矾-CpG上可诱导针对多种SARS-CoV-2变异株的广泛保护作用

期刊:

影响因子:

doi:10.1016/j.vaccine.2022.05.007

Pollet, Jeroen; Strych, Ulrich; Chen, Wen-Hsiang; Versteeg, Leroy; Keegan, Brian; Zhan, Bin; Wei, Junfei; Liu, Zhuyun; Lee, Jungsoon; Kundu, Rahki; Adhikari, Rakesh; Poveda, Cristina; Jose Villar, Maria; Rani Thimmiraju, Syamala; Lopez, Brianna; Gillespie, Portia M; Ronca, Shannon; Kimata, Jason T; Reers, Martin; Paradkar, Vikram; Hotez, Peter J; Elena Bottazzi, Maria

In vivo Serial Passaging of Human-Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication

人-猴免疫缺陷病毒克隆的体内连续传代培养揭示了病毒持续复制的特征

期刊:Frontiers in Microbiology

影响因子:4.5

doi:10.3389/fmicb.2021.779460

Thippeshappa, Rajesh; Polacino, Patricia; Chandrasekar, Shaswath S; Truong, Khanghy; Misra, Anisha; Aulicino, Paula C; Hu, Shiu-Lok; Kaushal, Deepak; Kimata, Jason T

Human

发表日期：2021

文献求助收藏

SARSâCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.

SARS-CoV-2 RBD219-N1C1：一种酵母表达的 SARS-CoV-2 重组受体结合域候选疫苗可刺激小鼠产生病毒中和抗体和 T 细胞免疫

期刊:Human Vaccines & Immunotherapeutics

影响因子:3.5

doi:10.1080/21645515.2021.1901545

Pollet Jeroen, Chen Wen-Hsiang, Versteeg Leroy, Keegan Brian, Zhan Bin, Wei Junfei, Liu Zhuyun, Lee Jungsoon, Kundu Rahki, Adhikari Rakesh, Poveda Cristina, Villar Maria Jose, de Araujo Leao Ana Carolina, Altieri Rivera Joanne, Momin Zoha, Gillespie Portia M, Kimata Jason T, Strych Ulrich, Hotez Peter J, Bottazzi Maria Elena

Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

生化标志物作为重症 COVID-19 入院早期指标的预测价值

期刊:Future Virology

影响因子:1.4

doi:10.2217/fvl-2020-0365

Rice, Andrew P; Kimata, Jason T; Yu, Yuanyuan; Li, Yan; Dong, Yu; Wang, Xuekun; Li, Chunxiao; Jiang, Wenqing; Gemcioglu, Emin; Davutoglu, Mehmet; Catalbas, Ramis; Karabuga, Berkan; Kaptan, Enes; Aypak, Adalet; Kalem, Ayse K; Özdemir, Mustafa; Yeşilova, Necati Y; Kalkan, Emra A; Civak, Musa; Kücüksahin, Orhan; Erden, Abdulsamet; Ates, Ihsan

发表日期：2021

文献求助收藏

Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV

作者更正：通过选择性清除能够产生HIV的宿主细胞来清除HIV感染

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-020-20218-9

Li, Min; Liu, Wei; Bauch, Tonya; Graviss, Edward A; Arduino, Roberto C; Kimata, Jason T; Chen, Min; Wang, Jin

Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses

清除含有完整前病毒的人类免疫缺陷病毒储存库

Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV

局部炎症小体抑制可减轻HIV皮下长效抗逆转录病毒疗法引起的异物反应。

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H

HIV-1 F 亚型整合酶催化核心结构域外部的多态性会导致整合酶抑制剂耐药突变 Q148H 背景下复制能力的严重丧失。

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies

通过促进细胞凋亡和抑制自噬清除HIV-1或SIV病毒库：以治愈为导向的策略中靶向细胞内分子

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

酵母表达的重组SARS-CoV-2受体结合域RBD203-N1作为COVID-19候选蛋白疫苗

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

受体结合域重组蛋白在明矾-CpG上可诱导针对多种SARS-CoV-2变异株的广泛保护作用

In vivo Serial Passaging of Human-Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication

人-猴免疫缺陷病毒克隆的体内连续传代培养揭示了病毒持续复制的特征

SARSâCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.

SARS-CoV-2 RBD219-N1C1：一种酵母表达的 SARS-CoV-2 重组受体结合域候选疫苗可刺激小鼠产生病毒中和抗体和 T 细胞免疫

Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

生化标志物作为重症 COVID-19 入院早期指标的预测价值

Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV

作者更正：通过选择性清除能够产生HIV的宿主细胞来清除HIV感染

Elimination of Human Immunodeficiency Virus Reservoirs Harboring Intact Proviruses

清除含有完整前病毒的人类免疫缺陷病毒储存库

Localized inflammasome inhibition mitigates foreign body response to subcutaneous long-acting antiretroviral therapy for HIV

局部炎症小体抑制可减轻HIV皮下长效抗逆转录病毒疗法引起的异物反应。

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H

HIV-1 F 亚型整合酶催化核心结构域外部的多态性会导致整合酶抑制剂耐药突变 Q148H 背景下复制能力的严重丧失。

Clearance of HIV-1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure-directed strategies

通过促进细胞凋亡和抑制自噬清除HIV-1或SIV病毒库：以治愈为导向的策略中靶向细胞内分子

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

酵母表达的重组SARS-CoV-2受体结合域RBD203-N1作为COVID-19候选蛋白疫苗

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

受体结合域重组蛋白在明矾-CpG上可诱导针对多种SARS-CoV-2变异株的广泛保护作用

In vivo Serial Passaging of Human-Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication

人-猴免疫缺陷病毒克隆的体内连续传代培养揭示了病毒持续复制的特征

SARSâCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.

SARS-CoV-2 RBD219-N1C1：一种酵母表达的 SARS-CoV-2 重组受体结合域候选疫苗可刺激小鼠产生病毒中和抗体和 T 细胞免疫

Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

生化标志物作为重症 COVID-19 入院早期指标的预测价值

Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV

作者更正：通过选择性清除能够产生HIV的宿主细胞来清除HIV感染

SARSâCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.